Skip to main content
Have a personal or library account? Click to login
Protective effects of manganese(II) chloride on hyaluronan degradation by oxidative system ascorbate plus cupric chloride Cover

Protective effects of manganese(II) chloride on hyaluronan degradation by oxidative system ascorbate plus cupric chloride

Open Access
|Apr 2010

References

  1. Archibald FS, Fridovich I. (1982). The scavenging of superoxide radical by manganous complexes:.: 452-463.
  2. Buettner GR, Jurkiewicz BA. (1993). Ascorbate free radical as a marker of oxidative stress: an EPR study.: 49-55.
  3. Buettner GB, Jurkiewicz BA. (1996). Catalytic metals, ascorbate and free radicals: combinations to avoid.: 532-541.
  4. Cavallini L, Valente M, Bindoli A. (1984). On the mechanism of inhibition of lipid peroxidation by manganese.: 117-120.
  5. Chang EC, Kosman DJ. (1989). Intracellular Mn (II)-associated superoxide scavenging activity protects Cu, Zn superoxide dismutase-deficient Saccharomyces cerevisiae against dioxygen stress.: 12172-12178.
  6. Cheton PL-B, Archibald FS. (1988). Manganese complexex and the generation and scavenging of hydroxyl radicals.: 325-333.
  7. Coassin M, Ursini F, Bindoli A. (1992). Antioxidant effect of manganese.: 330-333.
  8. Figueroa N, Nagy B, Charkrabarti B. (1977). Cu2+ -Hyaluronic acid complex: spectrophotometric detection. Biochem.: 460-465.
  9. Fisher AEO, Naughton DP. (2004). Iron supplements: The quick fix with long-term consequences.: 1-5.
  10. Fisher AEO, Naughton DP. (2005). Therapeutic chelators for the twenty first century: new treatments for iron and copper mediated inflammatory and neurological disorders.: 261-268.
  11. Fisher AEO, Naughton DP. (2003). Vitamin C contributes to inflammation via radical generating mechanisms: a cautionary note.: 657-660.
  12. Flemmig J, Arnhold J. (2007). Ferrous iron-induced strand breaks in the DNA plasmid pBR322 are not mediated by hydrogen peroxide.: 377-384.
  13. Gray B, Carmichael AJ. (1992). Kinetics of superoxide scavenging by dismutase enzymes and manganese mimics determined by electron spin resonance.: 795-802.
  14. Halliwell B, Foyer CH. (1976). Ascorbic acid, metal ions and the superoxide radical.: 697-700.
  15. Harris MJ, Herp A, Pigman W. (1976). Metal catalysis in the depolymerization of hyaluronic acid by autoxidants.: 7570-7572.
  16. Hussain S, Ali SF. (1999). Manganese scavenges superoxide and hydroxyl radicals: anstudy in rats.: 21-24.
  17. Johnson KA, Hulse DA, Hart RC, Kochevar D, Chut Q. (2001). Effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate on synovial fluid chondroitin sulfate 3B3 and 7D4 epitope in a canine cruciate ligament transection model of osteoarthritis.: 14-21.
  18. Khan MMT, Martell AE. (1967). Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. 2. Cupric and ferric chelate catalyzed oxidation.: 7104-7111.
  19. Khan MM, Martell AE. (1967). Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. I. Cupric and ferric ion catalyzed oxidation.: 4176-4185.
  20. Kogan G, Šoltés L, Stern R, Mendichi R. (2007) Chapter 31: Hyaluronic acid: A Biopolymer with Versatile Physico-Chemical and Biological Properties, in(Pethrick RA, Ballada A, Zaikov GE eds) pp. 393-439, New York, Nova Science Publishers.
  21. Kogan G, Šoltés L, Stern R, Schiller J, Mendichi R. (2008) Hyaluronic Acid: Its Function and Degradation in In Vivo Systems, in(Atta-ur-Rahman ed) pp. 789-882, Amsterdam, Elsevier.
  22. Koppenol WH. (1994). Chemistry of Iron and Copper in Radical Reactions, in(Rice-Evans CA, Burdon RH eds) pp. 3-24, Amsterdam, Elsevier Science B. V.
  23. Magnani A, Silvestri V, Barbucci R. (1999). Hyaluronic acid and sulphated hyaluronic acid in aqueous solution: effect of the sulphatation on the protonation and complex formation with Cuand Znions.: 2003-2014.
  24. Matsumura G, Pigman W. (1965). Catalytic role of iron ion in the depolymerization of hyaluronic acid by ascorbic acid.: 526-533.
  25. McCord JM. (1974). Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.: 529-531.
  26. Mendoza G, Álvarez AI, Pulido MM, Molina AJ, Merino G, Real R, Fernandes P, Prieto JG. (2007). Antioxidant profile of hyaluronan: physico-chemical features and its role in pathologies.: 96-102.
  27. Nagy L, Yamashita S, Yamaguchi T, Sipos P, Wakita H, Nomura M. (1998). The local structures of Cu(II) and Zn(II) complexes of hyaluronate.: 49-55.
  28. Naughton DP, Knappitt J, Fairburn K, Gaffnev K, Blake DR, Grootveld M. (1995). Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid.: 167-172.
  29. Niedermeier W, Dobson C, Laney RP. (1967a). Studies on the ascorbic acid-induced depolymerization of hyaluronic acid.: 366-373.
  30. Niedermeier W, Laney RP, Dobson C. (1967). The mechanism of action of ceruloplasmin in inhibiting ascorbic acid -induced depolymerization of hyaluronic acid.: 400-405.
  31. Niedermeier W, Griggs JH. (1971). Trace metal composition of synovial fluid and blood serum of patients with rheumatoid arthritis.: 527-536.
  32. Park JW, Chakrabarti B. (1978). Optical properties and viscosity of hyaluronic acid in mixed solvent: evidence of conformational transition biopolymers.: 1323-1333.
  33. Parsons BJ, Al-Assaf S Navaratnam S Phillips GO. (2002). Comparison of the Reactivity of Different Oxidative Species (ROS) towards Hyaluronan, in(Kennedy JF, Phillips GO, Williams PA, Hascall VC eds) pp. 141-150, Cambridge, MA, Woodhead Publishing Ltd.
  34. Pirc ET, Arčon I, Kodre A, Bukovec P. (2004). Metal-ion environment in solid Mn(II), Co(II) and Ni(II) hyaluronates.: 2549-2554.
  35. Roth JA. (2006). Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination.: 45-57.
  36. Rychlý J, Šoltés L, Stankovská M, Janigová I, Csomorová K, Sasinková V, Kogan G, Gemeiner P. (2006). Unexplored capabilities of chemiluminescence and thermoanalytical methods in characterization of intact and degraded hyaluronans.: 3174-3184.
  37. Qian SY, Buettner GR. (1999). Iron and dioxygen chemistry is an important route to initiation of biological free radical oxidations: an electron paramagnetic resonance spin trapping study.: 1447-1456.
  38. Sakurai K, Andoh M, Yamada M, KoderaY, Nishimura H, Hiroto M, Matsushima A, Aoyama M, Yamamoto H, Inadal Y. (1997). Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate.: 117-120.
  39. Samuni A, Aronovitch J, Godinger D, Chevion M, Czapski G. (1983). On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism.: 119-124.
  40. Shukla GS, Chandra SV. (1981). Manganese toxicity: Lipid peroxidation in rat brain.: 95-100.
  41. Shukla N, Maher J, Masters J, Angelini GD, Jeremy JY. (2006). Does oxidative stress change ceruloplasmin from a protective to a vasculopathic risk factor?: 238-250.
  42. Singh RK, Kooreman KM, Babbs CF, Fessler JF, Salaris SC. (1992). Potential use of simple manganese salts as antioxidant drugs in horses.: 1822-1829.
  43. Stankovská M, Šoltés L, Vikartovská A, Gemeiner P, Kogan G, Bakoš D. (2005). Degradation of high-molecular-weight hyaluronan: rotational viscometry study.(Suppl. 17): 149-152.
  44. Stankovská M, Šoltés L, Vikartovská A, Mendichi R, Lath D, Molnárová M, Gemeiner P. (2004). Study of hyaluronan degradation by means of rotational viscometry: contribution of the material of viscometer.: 348-352.
  45. Swann DA. (1967). The degradation of hyaluronic acid by ascorbic acid.: 42-44.
  46. Sziraki I, Mohanakumar KP, Rauhala P, Kim HG, Yeh KJ, Chiueh CC. (1998). Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of Parkinsonism.: 1101-1111.
  47. Sziraki I, Rauhala P, Koh KK, Bergen PV, Chiueh CC. (1999). Implications for atypical antioxidative properties of manganese in iron-induced brain lipid peroxidation and copper-dependent low density lipoprotein conjugation.: 455-466.
  48. Šoltés L, Kogan G, Stankovská M, Mendichi R, Rychlý J, Schiller J, Gemeiner P. (2007). Degradation of high-molar-mass hyaluronan and characterization of fragments.: 2697-2705.
  49. Šoltés L, Kogan G. (2009). Catabolism of hyaluronan: involvement of transition metals.: 229-238.
  50. Šoltés L, Stankovská M, Brezová V, Schiller J, Arnhold J, Kogan G, Gemeiner P. (2006). Hyaluronan degradation by copper(II) chloride and ascorbate: rotational viscometric, EPR spin-trapping, and MALDI-TOF mass spectrometric investigations.: 2826-2834.
  51. Šoltés L, Stankovská M, Kogan G, Gemeiner P, Stern R. (2005). Contribution of oxidative-reductive reactions to high-molecular-weight hyaluronan catabolism.: 1242-1245.
  52. Šoltés L, Valachová K, Mendichi R, Kogan G, Arnhold J, Gemeiner P. (2007). Solution properties of high-molar-mass hyaluronans: the biopolymer degradation by ascorbate.: 1071-1077.
  53. Tampo Y, Yonaha M. (1992). Antioxidant mechanism of Mn(II) in phospholipid peroxidation.: 115-20.
  54. Valko M, Morris H, Cronin MTD. (2005). Metals, toxicity and oxidative stress.: 1161-1208.
  55. Varani J, Ginsburg I, Gibbs DF, Mukhopadhyay PS, Sulavik C, Johnson KJ, Weinberg JM, Ryan US, Ward PA. (1991). Hydrogen peroxide-induced cell and tissue injury: protective effects of Mn.: 291-301.
  56. Volpi N. (2006). Therapeutic applications of glycosaminoglycans.: 1799-810.
  57. Weigel PH, DeAngelis PL. (2007). Hyaluronan synthases: a decade-plus of novel glycosyltransferases.: 36777-36781.
  58. Weissberger A, LuValle JE, Jr. Thomas DS. (1943). Oxidation processes. XVI. The autoxidation of ascorbic acid.: 1934-1939.
  59. Wong SF, Halliwell B, Richmond R, Skowroneck WR. (1981). The role of suproxide and hydroxyl radicals in the degradation of hyaluronic acid induced by metal ions and by ascorbic acid.: 127-134.
  60. Worley CG, Bombick D, Allen JW, Suber RL, Aschner M. (2002). Effects of manganese on oxidative stress in CATH.a cells.: 159-164.
DOI: https://doi.org/10.2478/v10102-010-0001-7 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 26 - 34
Published on: Apr 13, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2010 Katarína Valachová, Grigorij Kogan, Peter Gemeiner, Ladislav Šoltés, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.